Trusted by 1,000+ companies across 135+ countries, with 15+ years of FDA regulatory experience. Below: what goes on each panel, the ingredient rules brands get wrong, what MoCRA added, and the claims that turn a label into a problem.
FDA cosmetic labeling splits the required information between two areas of the package. Putting the right element in the right place is half of compliance.
| Principal Display Panel (PDP) | Information Panel |
|---|---|
| The front, most likely seen at retail | Usually right of the PDP, or on the back or side |
| Identity statement — what the product is | Ingredient declaration (INCI, descending order) |
| Net quantity of contents (U.S. + metric) | Name & place of business |
| Warnings, directions & the MoCRA adverse-event contact |
The ingredient declaration is where compliant labels most often slip. The rules under 21 CFR 701.3:
MoCRA introduced three label mandates beyond the FD&C Act and FPLA. Two are already in force; one is still on the way.
| MoCRA label addition | Status |
|---|---|
| Adverse-event contact (U.S. address, phone, or electronic) | Required since Dec 29, 2024 |
| “For professional use only” statement, plus full consumer labeling | Required since Dec 29, 2023 |
| Individual fragrance-allergen disclosure | Coming — FDA proposed rule expected in 2026, not yet final |
The adverse-event contact may be a website, but it must be a genuine channel the Responsible Person monitors — it ties the label to your post-market obligations.
Send us your label artwork and product details, and we'll check every element — identity, net quantity, INCI ingredients, business name, warnings, claims, and the MoCRA adverse-event contact — and align it with your facility registration and product listing, so you avoid reprints, detentions, and pulled listings. Email info@fdaregistrationassistance.com or call +1 (928) 275-8333.
At minimum: an identity statement and net quantity on the principal display panel; an ingredient declaration in INCI names and the name and place of business on the information panel; any required warnings; and, under MoCRA, a U.S. contact for adverse event reports — all in English.
The principal display panel (PDP) is the front, most likely seen at retail, and carries the product identity and net quantity. The information panel — usually to the right or on the back — carries the ingredient list, the business name and address, and warnings.
A clear statement of what the product is — “shampoo,” “moisturizing cream,” “lipstick” — displayed prominently on the PDP so consumers know the nature of the product (21 CFR 701.11).
In both U.S. customary units (ounces or fluid ounces) and metric units (grams or milliliters), placed in the bottom 30% of the PDP (21 CFR 701.13). Showing only one system is a common error.
Yes. The Fair Packaging and Labeling Act requires the net quantity of contents in both U.S. customary and metric units. Listing only one of the two is a labeling violation.
Use INCI names in descending order of predominance by weight. Ingredients present at 1% or less, and color additives, may be listed in any order after those present at more than 1% (21 CFR 701.3).
International Nomenclature of Cosmetic Ingredients — the standardized ingredient names the FDA recognizes for cosmetic labeling. Using a marketing or common name instead of the INCI name can make a label non-compliant.
Fragrance and flavor may currently be declared collectively as “fragrance” or “flavor,” and color additives listed after the 1% ingredients. A coming MoCRA rule will require individual fragrance-allergen disclosure.
The name and address of the manufacturer, packer, or distributor. If the named party isn't the maker, it must be qualified — for example “Manufactured for…” or “Distributed by…” (21 CFR 701.12).
Part 740 warnings apply to certain products — aerosols and self-pressurized containers, foaming bath products, feminine deodorant sprays, and products whose safety hasn't been substantiated, which must bear a specific safety warning.
Three things: a U.S. contact for adverse event reports (since Dec 29, 2024); a “professional use only” statement (since Dec 29, 2023); and fragrance-allergen disclosure, coming via a future rule. See our MoCRA overview.
Yes. Since December 29, 2024, every cosmetic label must carry a U.S. address, phone number, or electronic contact — a website is acceptable — through which the Responsible Person can receive adverse event reports.
Yes. Since December 29, 2023, professional-use cosmetics must state that they are for use by licensed professionals and must carry the same labeling as consumer products, including the full ingredient list.
Not yet. MoCRA directs the FDA to require individual fragrance-allergen labeling, but the rule defining which allergens and at what levels is still in development, with a proposed rule expected in 2026. Gathering allergen data now is wise.
No. The FDA does not approve cosmetics, so “FDA approved” is false and misleading and can itself trigger enforcement. You may state that your facility is “FDA registered” if it genuinely is.
When it claims to treat or prevent a condition, or to affect the body's structure or function — acne, anti-dandruff, SPF, antiperspirant. That shifts the product to an OTC drug — see OTC drug label compliance.
The FDA does not define “natural,” “hypoallergenic,” or “clean” for cosmetics, and “organic” may involve USDA rules. These claims aren't banned, but they must be truthful and not misleading.
Yes. Imported products must bear a country-of-origin marking under U.S. Customs rules, in addition to meeting all FDA cosmetic labeling requirements before entry.
English. If the label also uses another language, all required information must appear in that language too — not only in English — to remain compliant.
A cosmetic is misbranded if its labeling is false or misleading, omits required information, or isn't prominent enough to read (FD&C Act §602). Misbranding is a leading cause of import detention.
Very small or oddly shaped packages may use off-pack labeling — a tag, tape, or accompanying leaflet — for the ingredient declaration within FDA allowances, while identity and net quantity still appear on the container itself.
Yes. Under MoCRA, your label, facility registration, and product listing should be consistent — the Responsible Person on the label should match your listing records.
Yes. Marketplaces and retailers increasingly run their own label compliance reviews, and a non-compliant label can be rejected before the product ever reaches a consumer.
Review each element — identity, net quantity, ingredients, business name, warnings, and the MoCRA contact — against the FDA rules and correct the artwork before printing. Reviewing artwork before production avoids reprints and port problems.
Yes. We review cosmetic labels against the full FDA and MoCRA framework and align them with your registration and listing. Contact our team — email info@fdaregistrationassistance.com or call +1 (928) 275-8333.